Brenda S. Furlow - Dec 7, 2022 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
SVP - GENERAL COUNSEL
Signature
/s/ Andrew Nick as Attorney-in-Fact for Brenda S. Furlow pursuant to Power of Attorney previously filed
Stock symbol
TECH
Transactions as of
Dec 7, 2022
Transactions value $
-$419,500
Form type
4
Date filed
12/9/2022, 03:48 PM
Previous filing
Aug 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Options Exercise $25K +800 +3.07% $31.26 26.9K Dec 7, 2022 Direct
transaction TECH Common Stock Sale -$65.6K -800 -2.97% $82.01 26.1K Dec 7, 2022 Direct
transaction TECH Common Stock Options Exercise $233K +7.45K +28.55% $31.26 33.5K Dec 8, 2022 Direct
transaction TECH Common Stock Sale -$612K -7.45K -22.21% $82.12 26.1K Dec 8, 2022 Direct F1
holding TECH Common Stock 5.32K Dec 7, 2022 By Trust #1
holding TECH Common Stock 5.32K Dec 7, 2022 By Trust #2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Stock Options (Right to Buy) Options Exercise $0 -800 -2.1% $0.00 37.2K Dec 7, 2022 Common Stock 800 $31.26 Direct F2
transaction TECH Stock Options (Right to Buy) Options Exercise $0 -7.45K -20.02% $0.00 29.8K Dec 8, 2022 Common Stock 7.45K $31.26 Direct F2
holding TECH Stock Options (Right to Buy) 66.2K Dec 7, 2022 Common Stock 66.2K $44.33 Direct F2
holding TECH Stock Options (Right to Buy) 39.9K Dec 7, 2022 Common Stock 39.9K $47.60 Direct F2
holding TECH Stock Options (Right to Buy) 53.2K Dec 7, 2022 Common Stock 53.2K $47.60 Direct F3
holding TECH Restricted Stock Units 6.72K Dec 7, 2022 Common Stock 6.72K Direct F4, F5
holding TECH Stock Options (Right to Buy) 30K Dec 7, 2022 Common Stock 30K $66.97 Direct F5
holding TECH Stock Options (Right to Buy) 40K Dec 7, 2022 Common Stock 40K $66.97 Direct F6
holding TECH Stock Options (Right to Buy) $33.3K Dec 7, 2022 Common Stock $33.3K $66.97 Direct F7
holding TECH Stock Options (Right to Buy) 33.3K Dec 7, 2022 Common Stock 33.3K $66.97 Direct F8
holding TECH Stock Options (Right to Buy) 44K Dec 7, 2022 Common Stock 44K $93.11 Direct
holding TECH Restricted Stock Units 4.67K Dec 7, 2022 Common Stock 4.67K Direct F4, F9
holding TECH Stock Options (Right to Buy) 18.2K Dec 7, 2022 Common Stock 18.2K $120.46 Direct F9
holding TECH Stock Options (Right to Buy) 24.3K Dec 7, 2022 Common Stock 24.3K $120.46 Direct F10
holding TECH Stock Options (Right to Buy) 24.7K Dec 7, 2022 Common Stock 24.7K $94.52 Direct F11
holding TECH Restricted Stock Units 7.94K Dec 7, 2022 Common Stock 7.94K Direct F4, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from 82.0000 to 82.4900, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 Fully exercisable.
F3 Options to purchase13,292 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 13,288 shares vest on each of 8/7/2022 and 8/7/2023.
F4 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F5 Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F6 Options to purchase 9,992 shares vest on each of 8/5/2021 and 8/5/2022 and options to purchase 9,988 shares vest on each of 8/5/2023 and 8/5/2024.
F7 Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
F8 Options to purchase 11,100 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
F9 Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F10 Options to purchase 6,080 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.
F11 Options to purchase 6,168 shares vest on each of 8/15/2023 and 8/15/2025 and options to purchase 6,164 shares vest on 8/15/2024 and 8/15/2026.
F12 2,644 shares vest on each of 8/15/2023 and 8/15/2025, and 2,648 shares vest on 8/15/2024.

Remarks:

On November 28, 2022, the Company completed a four-for-one stock split. All common stock amounts and exercise prices in the filing relating to securities acquired prior to November 28, 2022 have been adjusted to reflect the four-for-one stock split.